Method for distinguishing between calcified atherosclerotic tissue and fibrous atherosclerotic tissue or normal cardiovascular tissue using Raman spectroscopy
OwnerRobert R. Alfano, Cheng H. Liuinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerRobert R. Alfano, Cheng H. Liuinventors
Estimating the term…
A method for distinguishing between calcified atherosclerotic tissue and either fibrous atherosclerotic tissue or normal cardiovascular tissue. The present method is based on the discovery that, when irradiated with a beam of monochromatic infrared light, calcified atherosclerotic human aortic tissue produces a Fourier Transform Raman spectrum which is distinguishable from analagous spectra obtained from fibrous atherosclerotic human aortic tissue and normal human aortic tissue. Some salient differences in the respective Raman spectra are the presence of five Raman bands at Raman shifts of 957, 1071, 1262-1300, 1445, and 1659 cm.sup.-1 (.+-.4 cm.sup.-1 for all shifts) for the calcified tissue as compared to three Raman bands at Raman shifts of 1247-1270, 1453 and 1659 cm.sup.-1 (.+-.4 cm.sup.-1 for all shifts) for the fibrous tissue and three Raman bands at Raman shifts of 1247-1270, 1449 and 1651 cm.sup.-1 (.+-.4 cm.sup.-1 for all shifts) for the normal tissue. In addition, it was discovered that the ratios of intensities for the Raman bands at 1659 and 1453 cm.sup.-1 and at 1254 and 1453 cm.sup.-1 were 0.69 and 0.53, respectively, for the calcified tissue, 1.02 and 0.85, respectively, for the fibrous tissue and 1.2 and 0.83, respectively, for the normal tissue.
A method for distinguishing between calcified atherosclerotic tissue and fibrous atherosclerotic tissue or normal cardiovascular tissue comprising the steps of:
A method of determining if a cardiovascular tissue sample is calcified atherosclerotic, on one hand, or fibrous atherosclerotic or normal, on the other hand, comprising the steps of:
A method of determining if a human aortic tissue sample is calcified atherosclerotic, on the one hand, or fibrous atherosclerotic or normal, on the other hand, comprising the steps of:
A method for determining whether a cardiovascular tissue sample is calcified atherosclerotic tissue as compared to fibrous atherosclerotic tissue or normal cardiovascular tissue comprising the steps of:
A method for determining whether a human aortic tissue sample is calcified atherosclerotic tissue as compared to fibrous atherosclerotic tissue or normal cardiovascular tissue comprising the steps of:
A method for determining whether a human aortic tissue sample is calcified atherosclerotic tissue as compared to fibrous atherosclerotic tissue or normal cardiovascular tissue comprising the steps of:
A method for determining if a human aortic tissue sample is calcified atherosclerotic as compared to fibrous atherosclerotic or normal, comprising the steps of:
A method for determining if a human aortic tissue sample is calcified atherosclerotic as compared to fibrous atherosclerotic or normal, comprising the steps of:
A system for determining if a cardiovascular tissue sample is calcified atherosclerotic as compared to fibrous atherosclerotic or normal, comprising:
A system for determining if a cardiovascular tissue sample is calcified atherosclerotic tissue as compared to fibrous atherosclerotic tissue or normal cardiovascular tissue, the system comprising:
A system for determining if a cardiovascular tissue sample is calcified atherosclerotic tissue as compared to fibrous atherosclerotic tissue or normal cardiovascular tissue, the system comprising:
A method for determining if a cardiovascular tissue sample is calcified atherosclerotic, fibrous atherosclerotic, or normal, comprising the steps of:
A system for determining if a cardiovascular tissue sample is calcified atherosclerotic, fibrous atherosclerotic, or normal, comprising:
A system for determining if a cardiovascular tissue sample is calcified atherosclerotic, fibrous atherosclerotic or normal, comprising:
Dependencies are inferred from the claim text.